NEW PHARMA THERAPIES
Sources: R. Winslow, WSJ 6-6-11, P. 1
Emerging ability of researchers to use
biomarkers to develop and exploit
new therapies for cancer and other diseases.
While it does not offer a ‘cure’,
it offers personalized routes for
treatment. 1
PATENT TROLLS AVOIDANCE
Source: S. Weinberg, WSJ 6-1-11
“Patent researcher turns tables on litigants“
Article One Partners advertises a product,
Litigation Avoidance, that aims to invalidate
poor quality patents that are held by
nonpracticing entities who seek to gain
from legal patent infringement.
Worth being aware of in high tech fields.
2
PETROCHEMICAL SUPPLY CHAIN
Source: S. Gold, WSJ 6-1-11, Exxon
fuels a chemicals drive,
ExxonMobil reported completing a
large raw petrochemical material project
in Singapore. It signals the continued
use of new supplies of petrochemicals and
positions for chemical engineers and
chemists.
June 14th, 2011 at 7:18 am
While there are all sorts of comments about who is
profiting, who is super-promoting, who is gaining, there
are REAL PATIENTS OUT THERE THAT ARE
BENEFITING.
That is who I look for.
Please view the comments like Amy Rausch fighting
breast cancer. Also see: P4 medicine is real and
advancing through intensive research:
http://www.systemsbiology.org/Intro_to_Systems_Biology/Predictive_Preventive_Personalized_and_Participatory